Medical company Sensus Healthcare Inc (Nasdaq:SRTS ) revealed on Monday the completion of its public offering of 2,205,882 common stock, par value USD0.01 per share.

All of the common stock shares were offered by the company at a public offering price of USD6.80 per share.

Before deducting underwriting discounts and commissions and estimated offering expenses, the company raised total proceeds from the offering of about USD15m.

The company has provided the underwriters with a 30-day option to purchase up to another 330,882 shares at the public offering price, less underwriting discounts and commissions.

Net proceeds from the offering may be used by the company primarily for general corporate purposes, research and development activities, expansion of its product lines and roll-out of new product offerings, capital expenditures, selling, general and administrative costs, facilities expansion as well as working capital.

For the offering, B Riley FBR acted as the lead underwriter and sole book-running manager. Craig-Hallum Capital Group and Roth Capital Partners acted as co-managers.